The growth in specialty drug spending is challenging how health systems and hospitals care for their patients. By 2018, specialty drugs will represent half of all drug sales, and by 2020, total volume is expected reach nearly half a trillion dollars. As specialty drugs grow in importance, they are also becoming more difficult to obtain.
To help with this dilemma, Vizient Inc. is offering a solution from Apexus called Acentrus. This product will put your organization at the center of a customized specialty pharmacy solution that aligns with your current capabilities and enhances your capacity over time. It protects your ability to serve your own patients, improve experience and outcomes through integrated care, and participate in value-based models that require accountability.
Acentrus is open to all hospitals and health systems that meet participation requirements. There currently is no initiation or annual participation fee.
If you are interested or have additional questions, you can contact your Vizient MidSouth liaison or Acentrus directly at (469) 299-7250 or email@example.com to learn more.